GNP Pink Bismuth tablets

Manufacturer
Amerisource Bergen | Guardian Drug Company
Effective date
2025-01-20
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:53:15

Label at a glance#

ProductGNP Pink Bismuth
Active ingredientBISMUTH SUBSALICYLATE
Label structure8 sections

Indications and uses

relieves: indigestion nausea heartburn diarrhea upset stomach associated with these symptoms

Dosage and administration

Swallow caplet(s) with water, do not chew adults and children 12 years and over: 2 caplets every 1/2 to 1 hour as needed do not take more than 8 doses (16 caplets) in 24 hours children under 12 years: ask a doctor drink plenty of fluids to help prevent dehydration which may accompany diarrhea.

Storage and handling

very low sodium, each caplet contains : calcium 27 mg, salicylate 102 mg and sodium 2 mg. TAMPER EVIDENT: Do not use if printed seal under cap is torn or missing. store at room temperature, in a dry place

Label contents#

Full prescribing information#

Active ingredient (in each caplet)

OTC - ACTIVE INGREDIENT SECTION

Bismuth subsalicylate 262 mg

(total salicylate 102 mg per caplet)

Purpose

OTC - PURPOSE SECTION

Upset stomach reliever and anti-diarrheal

Uses

INDICATIONS & USAGE SECTION

relieves:

  • indigestion
  • nausea
  • heartburn
  • diarrhea
  • upset stomach associated with these symptoms

Warnings

WARNINGS SECTION

Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. when using this product , if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.

Allergy alert:Contains salicylate. Do not take if you are

allergic to salicylates (including aspirin)

taking other salicylate products

Do not use if you have

OTC - DO NOT USE SECTION

  • bloody or black stool
  • an ulcer
  • a bleeding problem
Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • fever
  • mucus in the stool
Ask a doctor or pharmacist before use if you are taking any drug for

OTC - ASK DOCTOR/PHARMACIST SECTION

  • anticoagulation (thinning of the blood)
  • diabetes
  • gout
  • arthritis
When using this product

OTC - WHEN USING SECTION

a temporary, but harmless darkening of the stool and/or tongue may occur.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • symptoms get worse
  • ringing in the ears or loss of hearing occurs
  • diarrhea lasts more than 2 days
If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

OTC - PREGNANCY OR BREAST FEEDING SECTION

In case of overdose, get medical help or contact a poison control center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Swallow caplet(s) with water, do not chew
  • adults and children 12 years and over: 2 caplets every 1/2 to 1 hour as needed
  • do not take more than 8 doses (16 caplets) in 24 hours
  • children under 12 years: ask a doctor
  • drink plenty of fluids to help prevent dehydration which may accompany diarrhea.

Other information

STORAGE AND HANDLING SECTION

  • very low sodium, each caplet contains: calcium 27 mg, salicylate 102 mg and sodium 2 mg.
  • TAMPER EVIDENT: Do not use if printed seal under cap is torn or missing.
  • store at room temperature, in a dry place

Inactive ingredients

INACTIVE INGREDIENT SECTION

calcium carbonate, colloidal silicon dioxide, D&C red 27 aluminum lake, magnesium stearate, mannitol, microcrystalline cellulose, polysorbate 80, sodium starch glycolate.

PDP

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Good Neighbor Pharmacy

COMPARE TO PEPTO-BISMOL® ACTIVE INGREDIENT

protective coating

Pink Bismuth

Soothing relief for

: upset stomach, indigestion, nausea, heartburn and diarrhea

40 caplets

CartonCarton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
308760bismuth subsalicylate 262 MG Oral TabletPSN2
308760bismuth subsalicylate 262 MG Oral TabletSCD2

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
24385-017-58GNP Pink Bismuth1 in 1 CARTONTABLET12
24385-017-58GNP Pink Bismuth40 in 1 BOTTLETABLET402

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
24385-017GNP PINK BISMUTH (BISMUTH SUBSALICYLATE) TABLET [AMERISOURCE BERGEN]2Current NDC, Legacy NDC, 2 package rows20250121_9f5df648-298a-43e3-b250-8db6786fc93f.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
24385-017-58EA - Each24385-01714cdd9de-4ab8-4f1d-8652-1f1450a6158c12016-05-16

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
24385-01724385-017-58

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GNP Pink BismuthBISMUTH SUBSALICYLATEAmerisource Bergen9f5df648-298a-43e3-b250-8db6786fc93f2025-01-20WarningsExact identifier
ndc (package): 24385-017-58
ndc (product): 24385-017
ndc11 (package): 24385001758
spl id: 799c8c61-c421-4e8a-91ba-dad6cfbe9b9f
spl set id: 9f5df648-298a-43e3-b250-8db6786fc93f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.